Loading...
ROCO
8279
Market cap111mUSD
Nov 12, Last price  
129.00TWD
Name

Syngen Biotech Co Ltd

Chart & Performance

D1W1MN
ROCO:8279 chart
P/E
14.55
P/S
1.74
EPS
8.86
Div Yield, %
3.88%
Shrs. gr., 5y
Rev. gr., 5y
15.02%
Revenues
2.01b
+9.60%
1,311,436,0001,471,266,0001,930,594,0001,837,185,0002,013,592,000
Net income
240m
-12.60%
215,550,000237,770,000321,236,000274,827,000240,207,000
CFO
348m
-16.16%
0220,200,000336,498,000277,484,000415,130,000348,044,000
Dividend
Jun 27, 20245 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Syngen Biotech Co.,Ltd. engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicine. It also offers contract manufacturing; science-based and bio active pharmaceutical ingredients; and private labelling. In addition, the company provides organic food OEM/ODM, explosion proof extraction, brand agency, and wholesale distribution services. The company was founded in 1988 and is based in Tainan City, Taiwan.
IPO date
Nov 14, 2014
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT